Skye Bioscience Uplists to The Nasdaq Global Market

News
2024
2023
Archive
Search news articles

January 6, 2021

Artiva Biotherapeutics Announces Appointment of Dr. Fred Aslan as President and CEO
January 6, 2021

IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Crizotinib, a cMET Inhibitor
January 6, 2021

Homology Medicines Announces Plans for Three Clinical Programs in 2021 Spanning Phenylketonuria (PKU) and Hunter Syndrome (MPS II)
December 16, 2020

Scientist.com to Acquire HealthEconomics.Com, the World’s Leading Connected Community for Health Economics and Outcomes Research
December 15, 2020

NodThera Appoints Chief Medical Officer and Chief Financial Officer
December 15, 2020

Cidara Therapeutics Appoints Biotechnology Industry Veteran Christopher Kurtz as Executive Vice President of Technical Operations
December 14, 2020

Arvinas Releases Interim Clinical Data Further Demonstrating the Powerful Potential of PROTAC® Protein Degraders ARV-471 and ARV-110
December 11, 2020

Pear Therapeutics Announces Publication of Economic Analysis Assessing the Cost-Effectiveness of reSET-O® in Treating Opioid Use Disorder (OUD)
December 8, 2020

Cabaletta Bio Announces First Patient Dosed in Landmark DesCAARTes™ Trial of DSG3-CAART for Treatment of Mucosal-Dominant Pemphigus Vulgaris
December 8, 2020

Enliven Therapeutics Launches with Vision of Advancing Medicine and Restoring Lives